June 9, 2011
Recent News
View All
Monday, January 23, 2012
EntreMed Secures $10 Million Strategic Financing
Monday, November 14, 2011
EntreMed Reports Third Quarter 2011 Financial Results
Monday, October 3, 2011
EntreMed’s ENMD-2076 Demonstrates Promising Activity in a Phase 2 Study in Platinum-Resistant Ovarian Cancer Patients
Monday, August 15, 2011
EntreMed Reports Second Quarter 2011 Financial Results
Tuesday, June 28, 2011
EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown
Stay Informed
Enter your e-mail address to receive press releases electronically. (Manage your subscription)